Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Droller

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Bladder cancer: chemoprevention, complementary approaches and budgetary considerationsH Barton Grossman, Arnulf Stenzl, Mark A Moyad, et al.
Urologic Oncology|January 17, 2021
A history of the Society of Urologic OncologyPaul H Lange, Michael S Cookson, Paul F Schellhammer, et al.
The Journal of Urology|December 5, 2013
Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogateHugh J Lavery, Kristian D Stensland, Guenter Niegisch, et al.
Urologic Oncology|May 9, 2016
New Gleason grading system: Statement from the Editors of six journalsAnthony Zietman, Joseph Smith, Eric Klein, et al.
Urologic Oncology|October 2, 2012
PlagiarismMichael J Droller, , Robert R Bahnson, et al.
Journal of the National Cancer Institute|December 19, 2002
Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancerSteven Lehrer, Edward J Diamond, Michael J Droller, et al.
The Journal of Urology|November 21, 2002
Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasiaSteven Lehrer, Edward J Diamond, Nelson N Stone, et al.
European Urology|June 19, 2013
Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?Günter Niegisch, Anja Lorch, Michael J Droller, et al.
The Journal of Urology|May 15, 2007
A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter studyYves Fradet, H Barton Grossman, Leonard Gomella, et al.
BJU International|April 21, 2005
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancerSteven Lehrer, Edward J Diamond, Boris Mamkine, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Bladder cancer: chemoprevention, complementary approaches and budgetary considerationsH Barton Grossman, Arnulf Stenzl, Mark A Moyad, et al.
Urologic Oncology|January 17, 2021
A history of the Society of Urologic OncologyPaul H Lange, Michael S Cookson, Paul F Schellhammer, et al.
The Journal of Urology|December 5, 2013
Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogateHugh J Lavery, Kristian D Stensland, Guenter Niegisch, et al.
Urologic Oncology|May 9, 2016
New Gleason grading system: Statement from the Editors of six journalsAnthony Zietman, Joseph Smith, Eric Klein, et al.
Urologic Oncology|October 2, 2012
PlagiarismMichael J Droller, , Robert R Bahnson, et al.
Journal of the National Cancer Institute|December 19, 2002
Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancerSteven Lehrer, Edward J Diamond, Michael J Droller, et al.
The Journal of Urology|November 21, 2002
Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasiaSteven Lehrer, Edward J Diamond, Nelson N Stone, et al.
European Urology|June 19, 2013
Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?Günter Niegisch, Anja Lorch, Michael J Droller, et al.
The Journal of Urology|May 15, 2007
A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter studyYves Fradet, H Barton Grossman, Leonard Gomella, et al.
BJU International|April 21, 2005
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancerSteven Lehrer, Edward J Diamond, Boris Mamkine, et al.
Pageof 8